Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Aurinia Pharmaceuticals Inc - Common Shares
(NQ:
AUPH
)
16.02
-0.35 (-2.14%)
Streaming Delayed Price
Updated: 3:37 PM EDT, Jun 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aurinia Pharmaceuticals Inc - Common Shares
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Investor Action Alert: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm
April 22, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Shareholder Action Notice: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm
April 21, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Bronstein, Gewirtz & Grossman, LLC Notifies Aurinia Pharmaceuticals Inc. (AUPH) Investors of Class Action and Encourages Investors to Contact the Firm
April 21, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm
April 21, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Why Aurinia Pharmaceuticals Tumbled Despite Its 'Aggressive' 2022 Outlook
↗
February 28, 2022
The company expects 150%-200% growth in its key product. But that wasn't enough.
Via
Investor's Business Daily
Earnings Scheduled For February 28, 2022
↗
February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...
Via
Benzinga
Shareholder Update: Contact Robbins LLP to Learn More About the Class Action Against Aurinia Pharmaceuticals Inc. (AUPH)
April 20, 2022
From
Robbins LLP
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm
April 20, 2022
From
The Schall Law Firm
Via
Business Wire
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm
April 19, 2022
From
The Schall Law Firm
Via
Business Wire
Aurinia Announces Year-Two Commitment to Patient Navigation Grant Program to Address Barriers for Individuals Living with Lupus and Lupus Nephritis
April 19, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Aurinia Pharmaceuticals Inc. (AUPH)
April 19, 2022
From
Robbins LLP
Via
Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Aurinia Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – AUPH
April 18, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
AURINIA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Aurinia Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
April 15, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) Investor Notice: Investigation over Possible Violations of Securities Laws
↗
April 15, 2022
San Diego, CA -- (SBWIRE) -- 04/15/2022 -- An investigation was announced over potential securities laws violations by Aurinia Pharmaceuticals Inc. in connection with certain financial statements.
Via
SBWire
AUPH INVESTOR ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Inquire About Securities Class Action Investigation – AUPH
April 05, 2022
From
Rosen Law Firm
Via
Business Wire
Cramer Shares His Thoughts On PubMatic, Aurinia Pharmaceuticals And More
↗
April 05, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said although Kulicke and Soffa Industries, Inc.
Via
Benzinga
Aurinia Pharmaceuticals Announces Presentations at the 2022 National Kidney Foundation Spring Clinical Meetings
April 04, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm
March 16, 2022
From
The Schall Law Firm
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm
March 15, 2022
From
The Schall Law Firm
Via
Business Wire
AUPH INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Inquire About Securities Class Action Investigation AUPH
March 11, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
What 4 Analyst Ratings Have To Say About Aurinia Pharmaceuticals
↗
March 08, 2022
Over the past 3 months, 4 analysts have published their opinion on Aurinia Pharmaceuticals (NASDAQ:AUPH) stock. These analysts are typically employed by large Wall Street banks...
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
↗
March 08, 2022
Raymond James cut the price target on Ciena Corporation (NYSE: CIEN) from $80 to $75. Ciena shares fell 10.9% to close at $58.76 on Monday. Telsey Advisory Group cut Capri...
Via
Benzinga
42 Stocks Moving In Monday's Mid-Day Session
↗
February 28, 2022
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) jumped 74.4% to $1.20 after the company reported progress on solid-state polymer battery pack development. Renewable Energy Group...
Via
Benzinga
67 Biggest Movers From Yesterday
↗
March 01, 2022
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) climbed 145.6% to close at $1.69 on Monday after the company reported progress on solid-state polymer battery pack...
Via
Benzinga
Stocks Mixed as Investors Weigh Sanctions
↗
February 28, 2022
U.S. markets have cut a great deal of this morning's losses, though the Dow Jones Industrial Average (DJI) is still down
Via
Talk Markets
Why Aurinia Pharmaceuticals Shares Are Falling Today
↗
February 28, 2022
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is trading significantly lower Monday after the company reported declining fourth-quarter financial results on a year-over-year basis....
Via
Benzinga
Mid-Morning Market Update: Markets Open Lower Amid Ongoing Russia-Ukraine Conflict
↗
February 28, 2022
U.S. stocks opened on a downbeat note this morning, amid the ongoing Russia-Ukraine conflict, which has led to increased US sanctions on Russia. Following the market opening...
Via
Benzinga
Aurinia Reports Fourth Quarter and Full Year 2021 Financial Results and Company Updates
February 28, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2021 Financial Results on February 28, 2021
February 09, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Pharmaceuticals to Present at the 11th Annual Leerink Global Healthcare Conference
February 03, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
